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Abstract
Background:  A substantial body of research supports a genetic involvement in autism.
Furthermore, results from various genomic screens implicate a region on chromosome 7q31 as
harboring an autism susceptibility variant. We previously narrowed this 34 cM region to a 3 cM
critical region (located between D7S496 and D7S2418) using the Collaborative Linkage Study of
Autism (CLSA) chromosome 7 linked families. This interval encompasses about 4.5 Mb of genomic
DNA and encodes over fifty known and predicted genes. Four candidate genes (NRCAM, LRRN3,
KIAA0716, and LAMB1) in this region were chosen for examination based on their proximity to the
marker most consistently cosegregating with autism in these families (D7S1817), their tissue
expression patterns, and likely biological relevance to autism.
Methods:  Thirty-six intronic and exonic single nucleotide polymorphisms (SNPs) and one
microsatellite marker within and around these four candidate genes were genotyped in 30
chromosome 7q31 linked families. Multiple SNPs were used to provide as complete coverage as
possible since linkage disequilibrium can vary dramatically across even very short distances within
a gene. Analyses of these data used the Pedigree Disequilibrium Test for single markers and a
multilocus likelihood ratio test.
Results: As expected, linkage disequilibrium occurred within each of these genes but we did not
observe significant LD across genes. None of the polymorphisms in NRCAM, LRRN3, or KIAA0716
gave p < 0.05 suggesting that none of these genes is associated with autism susceptibility in this
subset of chromosome 7-linked families. However, with LAMB1, the allelic association analysis
revealed suggestive evidence for a positive association, including one individual SNP (p = 0.02) and
three separate two-SNP haplotypes across the gene (p = 0.007, 0.012, and 0.012).
Conclusions: NRCAM, LRRN3, KIAA0716 are unlikely to be involved in autism. There is some
evidence that variation in or near the LAMB1 gene may be involved in autism.
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Background
Autism is a severe neuro-developmental disorder that
manifests itself during the first three years of life and per-
sists throughout a patient's lifetime. Because of the fre-
quency with which it occurs, its severity, and its impact on
children and families, autism is a major public health con-
cern. It is estimated to occur in ~1/300 births, affecting
males three times more often than females. Autistic indi-
viduals display impairments in sociability, communica-
tion, and also demonstrate repetitive and/or obsessive-
compulsive behaviors [1-6].
A substantial body of data supports a genetic involvement
in the etiology of autism. Further data suggests that at least
one gene for autism lies on chromosome 7q22-31 [7-10].
Previously, the Collaborative Linkage Study of Autism
(CLSA) narrowed the 34 cM 7q22-31 critical region to a 3
cM region between D7S496 and D7S2418).)[11]. Four
genes within this region, Neuronal Cell Adhesion Mole-
cule (NRCAM) (XM_027222); Leucine Rich Repeat Pro-
tein Neuronal 3 ( LRRN3) (XM_045261); KIAA0716
(NM_014705); and Laminin Beta-1 (LAMB1)
(NM_002291) were chosen for further study. This choice
was based equally on their proximity to the microsatellite
marker (D7S1817) most consistently cosegregating in this
group of families, their tissue expression patterns, and
their likely biological relevance to the autism disease proc-
ess as described below.
The NRCAM gene encodes the Nr-CAM protein that is
expressed in structures in the developing brain, including
the floor plate. In this neuronal region, Nr-CAM has been
implicated in axonal guidance through interaction with
TAG-1/axonin-1 [12,13]. Additionally, when it is pre-
sented as a substrate in in vitro studies, Nr-CAM induces
neurite outgrowth from dorsal root ganglia neurons [13].
Nr-CAM also serves as a receptor for several different neu-
ronal recognition molecules. In its role as a receptor, it is
active during nervous system development in several dif-
ferent regions including the spinal cord, the visual system,
and the cerebellum [12].
Studies in Drosophila demonstrate that many members of
the LRR family provide an essential role in target recogni-
tion, axonal pathfinding, and cell differentiation during
neural development [14,15]. NLRR-3, the murine
ortholog of human LRRN3, was isolated using a human
brain cDNA fragment encoding an LRR as a probe against
a mouse brain cDNA [16]. NLRR-3 mRNA is expressed
abundantly in the brain and has very little expression in
other tissues. Its expression is developmentally regulated
and is confined to the nervous system. Its molecular struc-
ture and its expression pattern suggest that the NLRR-3
protein plays a role in the development and maintenance
of the murine nervous system through protein-protein
interactions [17,18]. These murine studies further
strengthen the relevance of the Drosophila results in that
these LRR proteins could have similar, if not the same,
integral functions in mammalian neural development.
Other studies have also implicated NLRR-3 as an impor-
tant component of the murine pathophysiological
response to brain injury [17]. Since LRRN3  is located
within this autism candidate region, and shares a high
degree of homology to NLRR-3, it was considered a strong
autism candidate gene.
Based on an hypothesis that large cDNAs (> 4 kb) encod-
ing large proteins (>50 kDA) in brain are likely to play an
important role in mammals, studies to identify such novel
genes have been performed [19]. During the course of
these analyses, the KIAA0716 cDNA was identified.
Although little is known about KIAA0716 and its protein
product, homology relationships suggest it is involved in
cell signaling and communication based on its similarity
to KIAA0299, which encodes the Dedicator of Cytokinesis
3 (DOCK3) protein. The DOCK proteins bind to the Src-
Homology 3 (SH3) domain of the v-crk sarcoma virus
CT10 oncogene homolog (CRK) protein and play an
important role in signaling from focal adhesions [20].
Laminin is a large molecular weight glycoprotein present
in basement membranes. Most laminin molecules are
comprised of an α chain and two β chains that are assem-
bled into a cruciform structure held together by disulfide
bonds. Three types of β chains (β1 chain, β2 chain, and β3
chain) have been described and are thought to contribute
to the functional variability of the members of the lam-
inin family. The laminin-B1 (LAMB1) gene encodes the
laminin B1 chain protein which is present at low levels in
serum and is involved in cell attachment and chemotaxis
presumably through its binding to the laminin receptor
(expressed highly in the brain) (reviewed in [21]). Data
from Xenopus studies demonstrate that laminin-1-beta is
important in axonal guidance during embryonic develop-
ment when it is co-expressed with netrin. More specifi-
cally, when netrin and laminin-1-beta are coexpressed,
axons are repulsed into the areas where only netrin, and
not laminin-1-beta, is present [22].
Based on their putative biological functions as well as
their genetic locations within our previously reported 3
cM chromosome 7 autism critical region [11], these four
neuronally expressed genes presented themselves as
intriguing autism candidate genes. Thirty six intronic and
exonic single nucleotide polymorphisms (SNPs) roughly
spaced at 10 kb intervals throughout these candidate
genes were analyzed via both single locus (Pedigree Dise-
quilibrium Test-PDT) and multilocus (TRANSMIT)
approaches. Additionally, Linkage Disequilibrium (LD)BMC Medical Genetics 2004, 5 http://www.biomedcentral.com/1471-2350/5/12
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relationships between all tested SNPs were examined
within the four candidates.
Methods
Sample composition
All probands met algorithm criteria of the Autism Diag-
nostic Interview-Revised (ADI-R) [23] and were at least
four years old. All probands were also assessed with the
Autism Diagnostic Observation Schedule (ADOS) [24] or
a later revision (ADOS-G). Affected sibling pair (ASP) and
trio families were recruited. Affected individuals were
excluded if they had fragile X syndrome, tuberous sclero-
sis, or any other medical condition known to be associ-
ated with autism.
Families were recruited from three regions of the United
States (Midwest, New England, and mid-Atlantic states)
through three clinical data collection sites: the University
of Iowa, Tufts University-New England Medical Center,
and Johns Hopkins University. The Institutional Review
Boards at each institution approved this study and appro-
priate informed consent was obtained from all subjects.
The sample was comprised of the 30 nuclear CLSA chro-
mosome 7 families as previously described).)[11]. Both
parents were available for genotyping in all but two fami-
lies. Twenty-nine families had two affected children while
one family had three affected children. Briefly, each of
these families had evidence for linkage within a 34 cM
region of chromosome 7q22-31 with LOD scores = 0.55.
Table 1: Primers used for candidate geneSNP assays.
Gene Assay ID Forward Primer Reverse Primer Product Size Major Allele 
Frequency
NRCAM RS427615 tttgaggcaacccaatagaatg cctgaccattttcccttcag 203 0.85
NRCAM RS381828 tcctgggatttactgcttgaa tctgtaatgaaagcaaagcatga 178 0.79
NRCAM RS414077 ctgccttggaaggtgaggat cggaattttctggaaaaacaaca 177 0.89
NRCAM RS401433 ccctagaagtcccgctttcc gtggcaccaccaaactgaag 183 0.75
NRCAM RS1043895 ccctagaagtcccgctttcc gtggcaccaccaaactgaag 183 0.78
NRCAM RS405945 atgtagtctgccacccatcc gctctcagtgctgggactct 173 0.75
NRCAM RS1269620 tgatcttgccggctctagtt catggtaccttgactctcttctca 176 0.80
NRCAM RS1269627 actgacagaggtcttgcaaat tggaaaggcctccataaaaa 160 0.80
NRCAM RS1269629 ccccaacagcttgacttcct gggtgggagcatgagagaga 124 0.54
NRCAM RS2072546 acttactggatgggcggaca ttttcctggacccgtaatgg 202 0.79
NRCAM RS1269634 gcgcttctttttcggcatta ctgcagacttccgctcttca 212 0.57
LRRN3 RS280282 ttgaagagcaacatggggta gatgattggggaaaatccaa 193 0.98
LRRN3 RS280306 tgtaccatgtggtaaaactgtaa gcagaagcatctaacaacagg 206 0.89
LRRN3 RS280309 actggctggagccacattatttt gaaaatgggcagaggtgaggtat 149 0.95
LRRN3 RS280310 caaaggcattgcttctgaaa tgtccttgtttctctgcctct 203 0.87
KIAA0716 RS1362155 tcctgacctcaggcgatactc tgctaggtgagagatagcagagaa 185 0.96
KIAA0716 RS1859746 gccatagggaacaatcacca ccatgcccttatatgcttgga 193 0.65
KIAA0716 RS757219 gctcaaaccatgaggattgc attacgtgggcaagcaaagg 195 0.90
KIAA0716 RS867915 tcccaattcactgctacctctg ccttgcagtgtgctgcctta 169 0.91
KIAA0716 RS718845 catggttggaagcctgtgtt tgaaaaccagacacgacctca 168 0.67
KIAA0716 RS1859025 aaggtttggaaagggcaggt tcccatggtgctttgtatca 224 0.72
KIAA0716 CV2541541RPT. tgtgggtaatttcacaatttgg ttcccatctttccagctgtc 180 0.31
KIAA0716 CV2541544 acaggagcccccaaataaat gacccaaatatcagacccaaaa 178 0.77
KIAA0716 CV339112 ggactttgtgcctggagttg cagtttctcacctgcttttgc 174 0.80
LAMB1 CVC8856543 ggtgatgttttattttgaagagca ggaaggagaagtccgttcact 160 0.67
LAMB1 CV11428541 cggacttctccttccagtctt ggtgggtcttttcacacagg 225 0.67
LAMB1 CV2193685 agggctaagtcctcattctcc caagatccaaagagcctcca 154 0.67
LAMB1 CV2193686 gatgagaggagggaggaagc ttcctgtgttttcaaggaagg 184 0.50
LAMB1 CV11428543 cctcaggcctagatggtgag tcctacctcccctctcttgc 177 0.60
LAMB1 CV2193689 ctgttttgggggttcctttt cttccctctgattggacagtg 145 0.61
LAMB1 CV3268606 cacagaccttggtcaagcag agacctttccaagccctgtt 201 0.63
LAMB1 CV2193712 ggctgggatcaactctttca tccagcttccaaaaagagga 200 0.88
LAMB1 CV152495 tgatctcaagcattcctcctg gaggattcactacccccaaa 176 0.74
LAMB1 CV2193721 cacgtacacgtgagggtgat tctgggaacaattcctggag 205 0.88
LAMB1 CV8428961 tgcacgatttaccacttagcc ggcctttcatcaggcaaat 226 0.60
LAMB1 CV1091266 gaggcctcacagtcataggc gtggcatgcagttgagtgac 190 0.83
LAMB1 CV2193735 aagacgcctgtcattgctg aaggcctgattgtgtgtgtg 153 0.52BMC Medical Genetics 2004, 5 http://www.biomedcentral.com/1471-2350/5/12
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The affected sibling pairs also shared a 3 cM region
between D7S496-D7S2418 (120 cM-123 cM) to a greater
extent than any other chromosome 7 region.
For exon screening analysis, twelve unrelated affected
individuals from these families were chosen because they
shared one or both of the two overtransmitted SNP hap-
lotypes (CV2193686/CV3268606 and CV1091266/
CV2193735).
Gene characterization and SNP choice
To determine the size and exon/intron structure of the
four candidate genes, the Celera, Ensembl, and NCBI
databases were used [25-27]. SNPs were chosen either
from the NCBI dbSNP database [28] or generated through
use of the Celera Discovery System and Celera Genomics'
associated databases. An "RS" number indicates SNPs
chosen from dbSNP while a "CV" number designates
SNPs chosen from Celera RefSNP. When available, SNPs
located in coding regions were chosen for analysis. In gen-
eral, a 10 kilobase (kb) spacing of SNPs was sought to
achieve as complete coverage as possible for a thorough
analysis of each candidate gene.
Primer design
Once SNPs were chosen, polymerase chain reaction (PCR)
primers were designed for single stranded conformational
polymorphism (SSCP) analysis using the Primer 3 web-
based PCR primer design software [29]. As part of the
primer design process, each forward and reverse primer
from the recommended pairs was compared against the
NCBI non-redundant (NR) and high throughput genomic
Table 2: LAMB1 exonic screening primer pairs. Capital letters indicate sequence within an exon. SNP assays were already run in the 
initial association studies using SNPs in exons 6 and 12.
Exon # Forward Primer Reverse Primer Product Size (bp)
1 cccttccatttcctgtcg gcaacctgaaaacccacct 440
2 ttccatccagtccctctcc gcgcctcttctctctttgaa 298
3 cgcttcctatctggattgct ccaactctgttgcctgtcct 314
4 tccaggcagtcaatctgtca aggagcttcatggggttttt 356
5 atccattttgaaaggggaca tgccagatgtcttgttccag 409
6 CV1091266 already run
7 gagcagatcacccgaggtt atgactgtgaggcctcgttt 556
8 aggtgcacagagggcttactt tttcatcttcttgatgaccttcc 252
9 aaaatgtcccttcaacacaga tggagaaacgtggctattcat 210
10 tcccacacagtgagtgacatt ttcttgacgttgctcttgtca 247
11 caaacacaagaaaactcccaaa gtgctttgcattcttctcagg 243
12 CV2193721 already run
13 ggaagactgaggacaagagca catgtttcacgttttgttctgc 144
14 ctgccacacactcccctact actcagctgatgtggctcct 191
15 cctcctccaccagtccacta aataaccattgtttgccatgc 220
16 atatgaagcccgttgagctg aggcagtggtgggctaactat 217
17 ccagaagcaatctcgcactta tggatgcatgaaggttgactt 200
18 actcagagccagaaacagcag gccgttctcatttcttcacag 274
19 ctgccacaatggctgagtta ctggcctctctttacccaca 224
20 gtctgctcagccagagatca gcagttccttgtttgcctgt 312
21 ctcccaaagtatgcacacga tggcctgttctcttctgtga 218
22 tgggcagaataaatgtgcatc tttggttttatcgggtgaca 271
22 tcattctaagaagtgggcagaa tgacacgacagacccagaag 172
23 cctgagctcataaaggcatca tgcctgtgtatttgggagtg 309
24 atcaagtcaatgcgagaacg cctgcttgaccaaggtctgt 162
25 accatgccaggaaatctttg gctagcattgcttattcccttc 477
26 tgggactatttgcaccaaaa acgtgaaagttctcccttgg 273
26 tgatcctcatttgtgccaga cagatattcggggtgagcat 159
27 cacatccccaaaccttacCA tgccttggatagcattacca 259
28 ctgaggccatccactgagtt gcctgatccttggcttgtt 249
29 cagagaatcacacagaaacaaatg tcatttttgagccatttcca 281
30 ccccttagatgccatgtcttt ggggacatctttgcttttca 258
31 aggtgtgttcccattcatgt tctgggtcatttcaggaagg 281
32 aggagactggtggctccttt ttgctggaaaattgacatgc 259
33 aaaataagcctgtgtgaaaagacc ccacttctttctgtctaaatgtgg 219
34 agggattcatcaacaatcagtg ggcatccatagtttatttaaaagtga 433BMC Medical Genetics 2004, 5 http://www.biomedcentral.com/1471-2350/5/12
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sequence (HTGS) sequence databases to determine
whether or not it was sufficiently specific for accurate PCR
amplification in the desired region. In some cases, it was
impossible to design a set of primers that were specific
enough for the SNP region (high numbers of BLAST hits
in many genomic regions), and new SNPs were chosen for
primer design and analysis. Table 1 lists the primer sets,
product sizes, and allele frequencies for each of the SNP
assays.
SNP assay testing and optimization
Two or more different SNP primer sets in the same 10 kb
region were designed and subjected to a preliminary
round of SSCP screening using 2 different conditions (15
Watts for 4 hours and 28 Watts for 1.5 hours at 4°C) to
ensure that the assays worked and to make a rough esti-
mation of allele frequencies in the test population. In the
preliminary screening, 14 unrelated control individuals
(28 chromosomes) were tested for each polymorphism.
An assay was considered successful, as well as sufficiently
polymorphic, when two or more individuals had a con-
sistently different banding pattern in the testing phase and
the assay was clear (i.e. a banding pattern with only three
possible genotypes representing a single SNP). After all of
the assays were initially tested, successful assays spaced at
regular intervals throughout the candidate genes were
chosen for analysis.
Table 3: Candidate gene association results (results given as nominal p-values)
Marker PDT Transmit H-W Test
NRCAM427615 0.80 0.11 1.00
NRCAM381828 0.25 0.08 0.61
NRCAM414077 0.16 0.39 0.75
NRCAM401433 1.00 0.33 0.88
NRCAM1043895 0.81 0.07 0.88
NRCAM405945 0.08 0.04 0.87
NRCAM1269620 0.43 0.78 0.85
NRCAM1269627 0.54 0.57 0.71
NRCAM1269629 0.35 0.15 1.00
NRCAM2072546 0.87 0.29 0.80
NRCAM1269634 0.16 0.95
LRRN280310 0.09 0.04 0.70
LRRN280309 0.32 0.11 0.75
LRRN280306 0.16 0.06 0.77
LRRN280282 1.00 0.63
KIAA1362155 0.32 0.10 0.68
KIAA1859746 0.14 0.04 0.35
KIAA757219 0.19 0.01 0.90
KIAA867915 0.18 0.59 0.97
KIAA718845 0.92 0.70 0.96
KIAA1859025 0.90 0.92
KIAACV2541541RPT 0.81 0.88
KIAA2541544 0.70 0.53 0.92
KIAA339112 0.35 0.94
LAMB8856543 0.67 0.26 0.45
LAMB11428541 0.37 0.26 0.62
LAMB2193685 0.35 0.05 0.47
LAMB2193686 0.12 0.42 0.69
LAMB11428543 0.47 0.01 0.76
LAMB2193689 0.10 0.01 0.68
LAMB3268606 0.17 0.10 0.95
LAMB2193712 0.26 0.06 0.78
LAMB152495 0.46 0.52 0.89
LAMB2193721 0.51 0.34 0.90
LAMB8428961 0.32 0.57 0.83
LAMB1091266 0.89 0.01 0.78
LAMB2193735 0.02 1.00BMC Medical Genetics 2004, 5 http://www.biomedcentral.com/1471-2350/5/12
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SNP genotyping
For the majority of the SNP genotyping work, PCR reac-
tions were set up according to standard procedures, dena-
tured at 95°C for 5 minutes, and subjected to SSCP on
0.5X MDE™ gels at 4°C. Individual SSCP gels were run
from 15–28 Watts for 1.5–5 hours depending on the pre-
vious test run. Gels were stained with Sybr® Gold nucleic
acid gel stain (Molecular Probes) and scanned on a
Hitachi FMBIOII fluoroimager (Hitachi Instruments, San
Jose, CA).
For assay RS280310, denaturing high performance liquid
chromatography (dHPLC) was performed using previ-
ously published methods on the Transgenomic WAVE™
[30]. In a WAVE™ analysis, all homozygous individuals
(regardless of their genotype) will yield a single dHPLC
peak whereas heterozygous individuals will yield 2–4
dHPLC peaks based on the melting temperature of the
PCR fragment heteroduplex or homoduplex and the
actual run conditions. Hence, initially it was impossible
for us to distinguish between an A/A homozygote and a C/
C homozygote. To unambiguously identify homozygous
genotypes, we chose three samples with homozygous
peak patterns and sequenced them to determine whether
or not they were A/A or C/C for the particular SNP. Next,
we pooled (in a 1:1 ratio) each of the unknown homozy-
gotes with a known (sequenced) homozygote (A/A) and
ran these samples on the WAVE™ again. Obtaining a
single peak indicated an A/A homozygote. Obtaining four
peaks indicated a C/C homozygote for this SNP. To cross-
validate the two genotyping methods, selected PCR
amplified samples from the RS280310 assay were also run
under SSCP conditions and blindly scored. Results were
consistent for every sample.
Microsatellite genotyping
During the characterization work of KIAA0716, we identi-
fied a novel polymorphic CA dinucleotide repeat within
intron 6 (the Celera genomic sequence contained (CA)18,
while the NCBI sequence contained (CA)22). A PCR assay
was designed, characterized, and applied to the dataset.
Primers were designed, controls were sized, and PCR
amplification and analysis was performed using standard
procedures. Briefly, PCR products were denatured and
electophoresed on 6% (Polyacrylamide Gel Electrophore-
sis, PAGE) denaturing gels. The gels were then stained
Table 4: Haplotype transmission for two-SNP haplotypes with nominal P < 0.05
Markers Haplotype Observed Expected χ2
NRCAM405945/1269620 1/1 38.0 31.4 5.4
1/2 0.0 0.0 NA
2/1 48.3 55.9 4.9
2/2 25.7 24.7 0.1
LRR280310/280309 1/1 0.1 1.1 2.2
1/2 91.4 95.3 3.1
2/1 7.3 4.5 4.0
2/2 13.2 11.1 1.3
KIAA1859746/757219 1/1 34.7 33.5 0.1
1/2 14.6 9.6 7.5
2/1 54.3 61.0 3.4
2/2 8.4 7.9 0.1
KIAA757219/867915 1/1 77.0 85.6 8.1
1/2 12.0 8.9 2.4
2/1 21.0 14.2 7.4
2/2 2.0 3.3 1.2
LAMB11428543/2193689 1/1 34.8 35.9 0.1
1/2 3.0 4.6 1.5
2/1 2.2 7.3 10.2
2/2 74.0 66.1 4.5
LAMB2193689/3268606 1/1 0.3 4.3 8.4
1/2 36.2 39.2 0.9
2/1 47.7 38.7 5.2
2/2 29.8 31.8 0.3
LAMB1091266/2193735 1/1 34.2 42.3 8.5
1/2 62.3 54.8 6.5
2/1 14.8 13.4 0.3
2/2 2.7 3.4 0.7BMC Medical Genetics 2004, 5 http://www.biomedcentral.com/1471-2350/5/12
Page 7 of 14
(page number not for citation purposes)
with Sybr® Gold nucleic acid gel stain (Molecular Probes,
Eugene, OR) and scanned on a Hitachi FMBIO II fluor-
oimager (Hitachi Instruments, San Jose, CA) using the
appropriate filter for detection and visualization of the
Sybr® Gold stained PCR fragments.
Exon screening
For LAMB1 exon screening analysis, denaturing high per-
formance liquid chromatography (dHPLC) was per-
formed via previously published methods using the
Transgenomic WAVE™ [30]. First, PCR primers were
designed for exonic amplification as previously described.
Second, the assays were tested for specificity via PCR
amplification and agarose gel electrophoresis. Third, the
exonic assays were amplified in 12 unrelated affected indi-
viduals and run on the WAVE™ under denaturing condi-
tions. Any samples with a discrepant dHPLC peak pattern
were reamplified and subjected to dye-primer or dye-ter-
minator sequencing using both forward and reverse prim-
ers. Table 2 lists the primer sets and PCR product size for
each of the exon screening assays.
Genotype error checking
Genotypes were checked for Mendelian consistency, SNP
haplotypes were constructed using SimWalk v2.0 [31],
plotted in Cyrillic (version 2.1. Oxford, Cherwell Scien-
tific Publishing), and all recombination events were iden-
tified. Haplotype reconstruction was based on
minimizing the number of recombination events on a
chromosome. In cases where apparent excess recombina-
tion was observed, gels were reread. If necessary, the SNP
assay was rerun to determine the most accurate genotype.
Once all of the data corrections were made, the haplo-
types generated from the SNP genotype information were
compared to the previously generated microsatellite
Gene structures for four candidate genes including SNP positions Figure 1
Gene structures for four candidate genes including SNP positions. Exonic SNPs are given in black, intronic SNPs in blue.
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marker haplotypes within and around the candidate
genes. In all cases, the haplotypes were consistent.
Genotype frequencies of each of the various SNPs were
also analyzed to determine that they conformed to Hardy-
Weinberg equilibrium based on the observed allele
frequencies.
Pedigree disequilibrium test (PDT)
Since a small number of families in our dataset were miss-
ing one parent or included half-siblings (one family), we
used the PDT [32] to test for association between autism
susceptibility and the genotyped SNPs. The PDT is an
extension of the Transmission Disequilibrium Test (TDT)
[33] that allows inclusion of extended families to test for
allelic association. It has been shown [34] that the PDT is
a valid and unbiased test of association even when linkage
exists.
Transmit
Haplotype analysis offers a valuable tool for investigating
associations between disease loci and multiple markers
[35]. Therefore, TRANSMIT [36] was applied to adjacent
two-SNP genotypes to determine whether any of these
haplotypes were preferentially transmitted. Three-SNP
haplotype analyses were not attempted due to the small
overall sample size. All sampled individuals were
included in the analyses.
Linkage disequilibrium (LD)
LD was assessed for the SNPs using the Graphical Over-
view of Linkage Disequilibrium (GOLD) program [37]
and characterized using the D' statistic [38].
Results
In the subset of CLSA families chosen for increased shar-
ing of the 4.5 Mb region of 7q31, we genotyped and ana-
Linkage Disequilibrium results for NRCAM Figure 2
Linkage Disequilibrium results for NRCAM. Each block represents the amount of LD between the indicated pair of SNPs.
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lyzed one microsatellite marker, 29 intronic SNPs, and
seven exonic SNPs (average spacing of 10 kb) derived
from the Celera RefSNP and NCBI dbSNP databases. Fig-
ure 1 gives the intron/exon structures and relative SNP
positions for each gene.
Once the genotype information was gathered and error
checking was performed, association analyses were carried
out to determine whether these genes are associated with
autism susceptibility. The results from the allelic and hap-
lotypic association analyses are given in Table 3. None of
the individual polymorphisms in or surrounding
NRCAM, LRRN3, or KIAA0716 demonstrated evidence for
allelic association to autism. However, this analysis did
reveal suggestive evidence for allelic association between
LAMB1  and autism susceptibility for one SNP
(CV2193735) located within intron 3 (p = 0.02). Exami-
nation of the two-SNP haplotypes produced marginally
significant results for at least one combination in
NRCAM, LRRN3, and KIAA0716. However, three different
two-SNP combinations within LAMB1 (CV11428543/
CV2193689  p  = 0.007 both within intron 25;
CV2193689/CV3268606 p = 0.012 within intron 25 and
intron 23; and CV1091266/CV2193735 p = 0.012 within
introns 6 and 3) displayed strongly significant results
(Table 4). All SNPs were in Hardy-Weinberg Equilibrium.
Examination of marker-to-marker linkage disequilibrium
identified discrete blocks of LD present within each of the
genes. With this set of SNPs, NRCAM has four such blocks
of LD defined by its 11 SNPs. The SNPs within LAMB1 dis-
played very strong LD in three blocks with a somewhat
weaker level of LD among a majority of the SNPs. Within
LRRN3, there is one SNP (RS280309) that seems to be in
strong LD with the majority of the other SNPs. The 8 SNPs
in KIAA0716 also comprise definite LD blocks although
Linkage Disequilibrium results for LRRN3 Figure 3
Linkage Disequilibrium results for LRRN3. Each block represents the amount of LD between the indicated pair of SNPs.
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they are not as tightly linked as those in NRCAM and
LAMB1. LD did not extend across these genes in the
broader region (data not shown). The LD results are
shown in Figures 2,3,4,5.
After observing the multiple suggestive allelic association
results in LAMB1, we screened its 34 exons for susceptibil-
ity variants using 12 unrelated affected individuals who
shared one or both of the overtransmitted haplotypes
(CV11428543/CV2193689–2/2 and CV1091266/
CV2193735–1/2). All of the exons were PCR-amplified in
these individuals and screened for variations via dHPLC
on the Transgenomic WAVE™. Whenever one of the
exonic assays displayed a discrepant dHPLC peak pattern
in any of the individuals, the exon was reamplified and
sequenced in the discrepant individual and a control with
forward and reverse primers.
13 of the 34 exonic assays had discrepant WAVE™ patterns
in at least one tested individual. 12 of the 13 discrepant
assays resulted in detectable SNPs while a SNP was not
observed via sequencing in the other discrepant assay. Six
of these detectable SNPs were in intronic flanking regions
(exonic assays 1, 2, 4, 5, 26, and 34) while the other six
were exonic. Four of the exonic SNPs resulted in synony-
mous codon substitutions (exonic assays 10, 15, 23, and
31) and the other two exonic SNPs created nonsynony-
mous amino acid changes (exonic assays 20 and 22). The
G/A SNP in exon 20 at mRNA position 2915 creates a
nonconserved glycine to serine change (G544S). A restric-
tion assay was utilized to determine if this SNP was over-
represented in unrelated autistic individuals taken from
the CLSA dataset (N = 90) compared to unrelated CEPH
controls (N = 80). No significant difference in the allele
frequencies between the two groups was found (χ2  =
0.2177 ; P = 0.64). The exon 22 SNP is an A/G change at
Linkage Disequilibrium results for KIAA0716 Figure 4
Linkage Disequilibrium results for KIAA0716. Each block represents the amount of LD between the indicated pair of SNPs.
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mRNA position 3402 creating a conserved glutamine to
arginine change (Q706R). We assayed this SNP via SSCP
in unrelated autistic probands taken from the CLSA and
Autism Genetic Resource Exchange (AGRE) datasets (N =
215) and unrelated CEPH controls (N = 73) to determine
if there was a difference in allele frequencies. We did not
observe a significant difference in allele frequencies
between the two groups (χ2 = 0.00 ; p = 1.00).
Discussion
Using a positional candidate gene approach we chose to
examine  LAMB1,  NRCAM, KIAA0716, and LRRN3  for
association to autism susceptibility.
Since it has been shown that using one or two SNPs is
insufficient for a thorough candidate gene/disease associ-
ation analysis [35], we chose multiple SNPs placed at reg-
ular intervals throughout these genes for our study.
Intronic and exonic SNPs were chosen to ensure that a
susceptibility variant or a variant in LD with a true suscep-
tibility allele would be detected. From this work, we
observed some evidence for association between LAMB1
and autism, including one individual SNP (CV2193735)
located within intron 3 (p = 0.02) and three separate two-
SNP haplotypes (CV11428543/CV2193689, CV2193689/
CV3268606, and CV1091266/CV2193735) across the
gene's transcriptional unit (p = 0.007, 0.012, and 0.012
respectively).
These results have not been corrected for multiple testing
since it is still unclear as to what level of correction should
be applied in an association study such as this. A Bonfer-
roni correction (p < .004 correcting on 12 tests and p <
.002 correcting on 24 tests) is too stringent to apply to
these data since these tests are not all based on independ-
ent data points. However, not correcting at all for multiple
Linkage Disequilibrium results for LAMB1 Figure 5
Linkage Disequilibrium results for LAMB1. Each block represents the amount of LD between the indicated pair of SNPs.
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tests will invariably lead to a high number of false posi-
tives in any study. The proper approach toward correction
for multiple comparisons has yet to be resolved. There-
fore, we provide the nominal results to allow the reader to
decide the level of error correction to apply.
Recently, it has been shown that LD varies markedly over
different chromosomal regions and distances. Further-
more, average LD measures cannot be accurately predicted
from one chromosomal region to another [39-41]. Hence,
we defined the pattern of LD to ensure that we had ade-
quate SNP coverage for our association study and
achieved a sufficient SNP spacing for an association exam-
ination to be performed. Given the recent studies showing
the tendency for LD to occur in "blocks" of DNA that can
range from ~5–100 kb [42,43] and the SNP coverage that
was achieved in this study, it was hardly surprising that we
observed distinct blocks of LD within these genes.
During the course of the LAMB1 exon screening, 2 SNPs
that led to amino acid changes were discovered in exons
20 and 22. The nonconserved amino acid change in exon
20 results in a glycine to serine substitution. This glycine
is located within one of the Laminin Epidermal Growth
Factor-like domains of the protein and has been evolu-
tionarily conserved in various species including Mus mus-
culus, Gallus gallus, Rattus Norvegicus, and C. elegans (Figure
6). Given the extent of the amino acid change from the
conformationally important glycine, which can confer a
large degree of local flexibility on its polypeptide, to ser-
ine, another residue that can have a large effect on the
local polypeptide conformation, and the extent of
evolutionary conservation of this particular amino acid
region among various species, it was somewhat surprising
to us that there was no significant difference in allele fre-
quencies between the autism and control groups. Regard-
less, even if this substitution changes the protein
Amino acid conservation among various organisms for human LAMB1 544G Figure 6
Amino acid conservation among various organisms for human LAMB1 544G.
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conformation or alters protein activity, we conclude that
it does not play a significant role in susceptibility to
autism. The other amino acid change that we observed
through exonic screening was within exon 22 and resulted
in a conserved glutamine to arginine change. This
glutamine is located within the myosin tail of the protein
and is not evolutionarily conserved across species (data
not shown).
Conclusions
Extensive SNP genotyping in three genes within the
autism candidate 7q31 region, NRCAM, LRRN3, and
KIAA0716 did not reveal any genomic variation associ-
ated with autism. However, some evidence of association
with a multi-locus haplotype in LAMB1 was observed.
Although exon screening did not discover a common var-
iation that alters the LAMB1 protein product in autistic
individuals, it is possible that disease susceptibility could
also be conferred from a variation in the gene's regulatory
region or from an intronic variant that impairs or alters
splicing. Thus LAMB1 remains a viable candidate gene
and may be associated with autism susceptibility in a sub-
set of autistic patients. Further testing of our genetic find-
ings in other datasets is required to definitively confirm or
negate these results.
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